Serum concentrations of insulin, ghrelin, adiponectin, leptin, leptin receptor and lipocalin-2 in children with celiac disease who do and do not adhere to a gluten-free diet

Gut and Liver

Volumn 10, Issue 4, 2016, Pages 587-594

  Janas, Roman M ^a   Rybak, Anna ^a   Wierzbicka Ruciska, Aldona ^a   Socha, Piotr ^a   Snitko, Rafa ^a   Szaflarska Popawska, Anna ^b   Stolarczyk, Anna ^a   Oralewska, Beata ^a   Cytra Jarocka, Elbieta ^c   Iwaczak, Barbara ^d   Grzybowska Chlebowczyk, Urszula ^e   Cichy, Wojciech ^f   Czaja Bulsa, Grayna ^g   Socha, Jerzy ^a  

^a CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^b NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^c MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^d UNIVERSITY OF WROC AW   (Poland)

^e MEDICAL UNIVERSITY OF SILESIA   (Poland)

^f POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^g POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Celiac disease; Diet, gluten free; Ghrelin; Insulin; Lipocalin 2

Indexed keywords

ADIPONECTIN; GHRELIN; INSULIN; LEPTIN; LEPTIN RECEPTOR; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; ADIPOQ PROTEIN, HUMAN; LCN2 PROTEIN, HUMAN; PEPTIDE HORMONE;

ADOLESCENT; ARTICLE; CELIAC DISEASE; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIETARY COMPLIANCE; FEMALE; GLUTEN FREE DIET; HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PREPUBERTY; PRESCHOOL CHILD; PROTEIN BLOOD LEVEL; PUBERTY; BLOOD; DIET THERAPY; PATIENT COMPLIANCE;

ADIPONECTIN; ADOLESCENT; CELIAC DISEASE; CHILD; CHILD, PRESCHOOL; DIET, GLUTEN-FREE; FEMALE; GHRELIN; HUMANS; INSULIN; LEPTIN; LIPOCALIN-2; MALE; PATIENT COMPLIANCE; PEPTIDE HORMONES; RECEPTORS, LEPTIN;

EID: 84978532208     PISSN: 19762283     EISSN: None     Source Type: Journal    
DOI: 10.5009/gnl15404     Document Type: Article

References (46)

1. Green PH, Cellier C. Celiac disease. N Engl J Med 2007;357:1731-1743.
2. Guandalini S, Assiri A. Celiac disease: a review. JAMA Pediatr 2014;168:272-278.
3. Hill ID, Dirks MH, Liptak GS, et al. Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2005;40:1-19.
4. Husby S, Koletzko S, Korponay-Szabó IR, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 2012;54:136-160.
5. McGowan KE, Castiglione DA, Butzner JD. The changing face of childhood celiac disease in North America: impact of serological testing. Pediatrics 2009;124:1572-1578.
6. Brambilla P, Picca M, Dilillo D, et al. Changes of body mass index in celiac children on a gluten-free diet. Nutr Metab Cardiovasc Dis 2013;23:177-182.
7. Tucker E, Rostami K, Prabhakaran S, Al Dulaimi D. Patients with coeliac disease are increasingly overweight or obese on presentation. J Gastrointestin Liver Dis 2012;21:11-15.
8. Wieser H, Koehler P. The biochemical basis of celiac disease. Cereal Chem 2008;85:1-13.
9. Garrote JA, Gómez-González E, Bernardo D, Arranz E, Chirdo F. Celiac disease pathogenesis: the proinflammatory cytokine network. J Pediatr Gastroenterol Nutr 2008;47 Suppl 1:S27-S32.
10. Boguszewski MC, Cardoso-Demartini A, Geiger Frey MC, Celli A. Celiac disease, short stature and growth hormone deficiency. Transl Gastrointest Cancer 2015;4:69-75.
11. Gujral N, Freeman HJ, Thomson AB. Celiac disease: prevalence, diagnosis, pathogenesis and treatment. World J Gastroenterol 2012;18:6036-6059.
12. Spatola BN, Kaukinen K, Collin P, Mäki M, Kagnoff MF, Daugherty PS. Persistence of elevated deamidated gliadin peptide antibodies on a gluten-free diet indicates nonresponsive coeliac disease. Aliment Pharmacol Ther 2014;39:407-417.
13. Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 1999;11:1185-1194.
14. Kabbani TA, Kelly CP, Betensky RA, et al. Patients with celiac disease have a lower prevalence of non-insulin-dependent diabetes mellitus and metabolic syndrome. Gastroenterology 2013;144:912-917.e1.
15. Tortora R, Capone P, De Stefano G, et al. Metabolic syndrome in patients with coeliac disease on a gluten-free diet. Aliment Pharmacol Ther 2015;41:352-359.
16. Valentini L, Wirth EK, Schweizer U, et al. Circulating adipokines and the protective effects of hyperinsulinemia in inflammatory bowel disease. Nutrition 2009;25:172-181.
17. Bregenzer N, Hartmann A, Strauch U, Schölmerich J, Andus T, Bollheimer LC. Increased insulin resistance and beta cell activity in patients with Crohn's disease. Inflamm Bowel Dis 2006;12:53-56.
18. Lanzini A, Magni P, Petroni ML, et al. Circulating ghrelin level is increased in coeliac disease as in functional dyspepsia and reverts to normal during gluten-free diet. Aliment Pharmacol Ther 2006;23:907-913.
19. Capristo E, Farnetti S, Mingrone G, et al. Reduced plasma ghrelin concentration in celiac disease after gluten-free diet treatment. Scand J Gastroenterol 2005;40:430-436.
20. Peracchi M, Conte D, Terrani C, et al. Circulating ghrelin levels in celiac patients. Am J Gastroenterol 2003;98:2474-2478.
21. Selimoglu MA, Altinkaynak S, Ertekin V, Akcay F. Serum ghrelin levels in children with celiac disease. J Clin Gastroenterol 2006;40:191-194.
22. Kempiski R, Demissie M, Jasiska M, Paradowski L. Plasma ghrelin concentration in celiac patients. Gastroenterol Pol 2008;15:375-377.
23. Tomasik PJ, Grzenda-Adamek Z, Sztefko K, Fyderek K. The orexigenic peptides in children with celiac disease. J Appl Res 2009;9:70-75.
24. Karmiris K, Koutroubakis IE, Xidakis C, Polychronaki M, Voudouri T, Kouroumalis EA. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease. Inflamm Bowel Dis 2006;12:100-105.
25. Karmiris K, Koutroubakis IE, Kouroumalis EA. Leptin, adiponectin, resistin, and ghrelin: implications for inflammatory bowel disease. Mol Nutr Food Res 2008;52:855-866.
26. Deboer MD. Use of ghrelin as a treatment for inflammatory bowel disease: mechanistic considerations. Int J Pept 2011;2011:189242.
27. Manavalan JS, Hernandez L, Shah JG, et al. Serum cytokine elevations in celiac disease: association with disease presentation. Hum Immunol 2010;71:50-57.
28. Jarocka-Cyrta E, Kasacka I, Kaczmarski M. The ghrelin-positive cells number is increased in duodenum in children with celiac disease. J Endocrinol Invest 2010;33:165-170.
29. Russo F, Chimienti G, Clemente C, et al. Adipokine profile in celiac patients: differences in comparison with patients suffering from diarrhea-predominant IBS and healthy subjects. Scand J Gastroenterol 2013;48:1377-1385.
30. Shetty S, Kusminski CM, Scherer PE. Adiponectin in health and disease: evaluation of adiponectin-targeted drug development strategies. Trends Pharmacol Sci 2009;30:234-239.
31. Batra A, Zeitz M, Siegmund B. Adipokine signaling in inflammatory bowel disease. Inflamm Bowel Dis 2009;15:1897-1905.
32. Weigert J, Obermeier F, Neumeier M, et al. Circulating levels of chemerin and adiponectin are higher in ulcerative colitis and chemerin is elevated in Crohn's disease. Inflamm Bowel Dis 2010;16:630-637.
33. Paul G, Schäffler A, Neumeier M, et al. Profiling adipocytokine secretion from creeping fat in Crohn's disease. Inflamm Bowel Dis 2006;12:471-477.
34. Herfarth HH, Martin CF, Sandler RS, Kappelman MD, Long MD. Prevalence of a gluten-free diet and improvement of clinical symptoms in patients with inflammatory bowel diseases. Inflamm Bowel Dis 2014;20:1194-1197.
35. Waluga M, Hartleb M, Boryczka G, Kukla M, Zwirska-Korczala K. Serum adipokines in inflammatory bowel disease. World J Gastroenterol 2014;20:6912-6917.
36. Bolignano D, Della Torre A, Lacquaniti A, Costantino G, Fries W, Buemi M. Neutrophil gelatinase-associated lipocalin levels in patients with Crohn's disease undergoing treatment with infliximab. J Investig Med 2010;58:569-571.
37. Chan JL, Blüher S, Yiannakouris N, Suchard MA, Kratzsch J, Mantzoros CS. Regulation of circulating soluble leptin receptor levels by gender, adiposity, sex steroids, and leptin: observational and interventional studies in humans. Diabetes 2002;51:2105-2112.
38. Kratzsch J, Lammert A, Bottner A, et al. Circulating soluble leptin receptor and free leptin index during childhood, puberty, and adolescence. J Clin Endocrinol Metab 2002;87:4587-4594.
39. Ertekin V, Orbak Z, Selimoglu MA, Yildiz L. Serum leptin levels in childhood celiac disease. J Clin Gastroenterol 2006;40:906-909.
40. Maggio MC, Corsello G, Iacono G, et al. Gluten-free diet impact on leptin levels in asymptomatic coeliac adolescents: one year of follow-up. Horm Res 2007;67:100-104.
41. Aurangzeb B, Leach ST, Lemberg DA, Day AS. Assessment of nutritional status and serum leptin in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2011;52:536-541.
42. Jönsson T, Memon AA, Sundquist K, et al. Digested wheat gluten inhibits binding between leptin and its receptor. BMC Biochem 2015;16:3.
43. Ockenga J, Tietge UJ, Böker KH, Manns MP, Brabant G, Bahr MJ. Distinct roles of free leptin, bound leptin and soluble leptin receptor during the metabolic-inflammatory response in patients with liver cirrhosis. Aliment Pharmacol Ther 2007;25:1301-1309.
44. Singer E, Markó L, Paragas N, et al. Neutrophil gelatinase-associated lipocalin: pathophysiology and clinical applications. Acta Physiol (Oxf) 2013;207:663-672.
45. Janas RM, Ochociska A, nitko R, et al. Neutrophil gelatinaseassociated lipocalin in blood in children with inflammatory bowel disease. J Gastroenterol Hepatol 2014;29:1883-1889.
46. Oikonomou KA, Kapsoritakis AN, Theodoridou C, et al. Neutrophil gelatinase-associated lipocalin (NGAL) in inflammatory bowel disease: association with pathophysiology of inflammation, established markers, and disease activity. J Gastroenterol 2012;47:519-530.